Correction to: Policy recommendations for promoting nuclear medicine therapy in Japan 2025, from the Working Group for promoting nuclear medicine therapy of the Japan Society of Clinical Oncology. [PDF]
Suzuki K +15 more
europepmc +1 more source
Fluorination augments tumor engagement and antitumor immunity of a D-peptide-based radiotheranostic agent for combinatorial immune checkpoint blockade therapy. [PDF]
Zhang S +15 more
europepmc +1 more source
Establishment of National Diagnostic Reference Levels 2025 for nuclear medicine in Japan. [PDF]
Abe K +14 more
europepmc +1 more source
Variability of the arterial input function in small-animal dynamic PET imaging. [PDF]
Kuttner S +5 more
europepmc +1 more source
<sup>18</sup>F-Radiopharmaceutical Diversification Enabled by Deaminative Cross-Electrophile Couplings. [PDF]
Ogilvy IF +13 more
europepmc +1 more source
Streamlining first-in-human PET radiopharmaceutical development: FDA's evolving stance on preclinical dosimetry. [PDF]
Zhao T, Liang SH.
europepmc +1 more source
A Novel <sup>68</sup>Ga-Labeled Integrin α4β7-Targeted Radiopharmaceutical for PET/CT Imaging of DSS-Induced Murine Colitis. [PDF]
Yang G, Zhang H, Huo L.
europepmc +1 more source
Deep learning-based radiolabelled compound-protein interaction prediction for NDUFS1-targeting radiopharmaceutical discovery. [PDF]
Almaslamani M +5 more
europepmc +1 more source

